Hbk Investments L P Clovis Oncology, Inc. Transaction History

Hbk Investments L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $863,717 - $1.17 Million	-17,233 Reduced 20.49%	66,873 $3.53 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $3.31 Million - $4.86 Million	57,442 Added 215.43%	84,106 $5.72 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $1.79 Million - $2.26 Million	26,664	26,664 $2.2 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.